Dartmouth-Hitchcock Board of Trustees Names Three New Members
Dartmouth-Hitchcock’s Board of Trustees elected three new members at the Board’s spring meeting on March 20, 2015.
Troyen A. (“Troy”) Brennan, MD, MPH; M. Brooke Herndon, MD, MS; and Charles G. (“Charlie”) Plimpton were unanimously elected to the 20-member volunteer board, joining colleagues from around the nation as well as from the Upper Valley in the leadership of New Hampshire’s largest health system.
“We are delighted and honored to welcome Troy, Brooke, and Charlie to our board,” said D-H Trustees Chair Robert Oden, PhD. “Their experience, and their passion for health care and for Dartmouth-Hitchcock make them all welcome additions. I look forward to their leadership as we continue to chart the future of the Dartmouth-Hitchcock system, creating a sustainable health system to improve the lives of the people and communities we serve for generations to come.”
Brennan is Executive Vice President and Chief Medical Officer of CVS Health. In this role, Troy has responsibility for CVS Health’s health care and wellness programs.
Previously, Brennan was Chief Medical Officer of Aetna Inc. Prior to that, he served as president of the Brigham and Women's Physicians Organization. In his academic work, he was Professor of Medicine at Harvard Medical School and Professor of Law and Public Health at Harvard School of Public Health.
He received MD and MPH degrees from Yale Medical School and a JD degree from Yale Law School. He completed his internship and residency in internal medicine at Massachusetts General Hospital. He is a member of the Institute of Medicine of the National Academy of Sciences.
Herndon joined the faculty of Dartmouth-Hitchcock and the Geisel School of Medicine in 2001 as an Assistant Professor in the Section of General Internal Medicine. She focuses on primary care practice and innovation, with a special interest in the care of complex, frail patients in the outpatient setting. In addition to maintaining a practice at the Heater Road Primary Care Clinic, Brooke serves as the Clinical Lead for Chronic Conditions for the High Value Health Care Collaborative (HVHC). She is also the Project Leader for D-H’s HVHC Complex Patient project, which is aimed at building a strong care management infrastructure to support improved quality and reduced costs for complex patients with chronic conditions.
She graduated from Princeton University with a degree in comparative literature. She enrolled in a post-baccalaureate program at the University of Pennsylvania, where she also completed her first two years of medical school. She received her MD from the UCLA School of Medicine and completed her residency in internal medicine/primary care at UCLA. Dr. Herndon received her MS in Clinical and Health Services Research at The Dartmouth Institute for Health Policy and Clinical Practice (TDI) in 2013.
Plimpton retired from Wall Street in 2012, having worked at Citigroup, Merrill Lynch and a predecessor firm to UBS. His 31-year investment banking career was devoted exclusively to serving the non-profit segment of the health care industry. During this time span, he witnessed and participated in profound changes to the U.S. health care delivery system, including the introduction of DRGs, the evolution of managed care, national health care reform debate and enactment, provider diversification followed by consolidation, and the current wave of horizontal and vertical integration.
He was lead banker to a wide variety of exempt health care organizations including vertically integrated providers, academic medical centers, research institutes, pediatric referral centers, multi-state hospital systems, and virtual provider organizations bound together through joint operating agreements.
Plimpton received his BA from the University of Pennsylvania and his MBA from The Tuck School at Dartmouth. Upon his retirement, his wife Barbara and he returned to the Upper Connecticut River Valley and currently live in Cornish, NH.
Brennan, Herndon, and Plimpton join other Dartmouth-Hitchcock Board of Trustees members including:
- Robert A. Oden, Jr. PhD
- Duane A. Compton, PhD
- William J. Conaty
- Vincent S. Conti
- Denis A. Cortese, MD
- Barbara J. Couch
- Paul P. Danos, PhD
- Sen. Judd A. Gregg
- Laura K. Landy
- Steven A. Paris, MD
- Anne-Lee Verville
- James N. Weinstein, DO, MS
Dartmouth-Hitchcock (D-H) is a nonprofit academic health system that serves a population of 1.9 million in New England. D-H provides access to more than 1,000 primary care doctors and specialists in almost every area of medicine, delivering care in Lebanon, NH at its flagship, Dartmouth-Hitchcock Medical Center; the Norris Cotton Cancer Center, one of only 45 Comprehensive Cancer Centers in the nation; the Children's Hospital at Dartmouth-Hitchcock; affiliate hospitals in Lebanon, Keene, and New London, NH, and Windsor, VT, and through the Visiting Nurse and Hospice for Vermont and New Hampshire; and at 24 Dartmouth-Hitchcock clinics that provide ambulatory services across New Hampshire and Vermont. The D-H system trains nearly 400 residents and fellows annually, and performs world-class research, in partnership with the Audrey and Theodor Geisel School of Medicine at Dartmouth and the White River Junction VA Medical Center in White River Junction, VT. In 2016, Dartmouth-Hitchcock Medical Center was named one of "100 Great Hospitals in America" by Becker's Hospital Review.